An Estimate of the Variance of Estimators for Lead Time and Screening Benefit in Randomized Cancer Screening Trials
نویسندگان
چکیده
Variance estimators are derived for estimators of the average lead time and average benefit time due to screening in a randomized screening trial via influence functions. The influence functions demonstrate that these estimators are asymptotically equivalent to the mean difference, between the study and control case groups, in the survival times. For estimating benefit time, the survival time is measured since start of study; for estimating lead time, the survival time is measured since time of diagnosis. Asymptotic variances of these estimators can be calculated in a straightforward manner from the influence functions, and these variances can be estimated from actual trial data. The performance of the variance estimates is assessed via a simulated screening trial. The situation involving censored data is also discussed.
منابع مشابه
Health education models application by peer group for improving breast cancer screening among Iranian women with a family history of breast cancer: A randomized control trial
Background: Studies have shown that participation of Iranian women with family history of breast cancer in screening service is low. This investigation has evaluated the effectiveness of health models according to peer group in improving clinical breast exam (CBE) among Iranian women with a family history of breast cancer. Methods: This was a randomized control ...
متن کاملPSA Screening in Prostate Cancer
Introduction: Prostate cancer is one of the most common cancers in Iranian men. PSA(prostate specific antigen) screening is a controversial issue because PSA screening leads to diagnose of patients with low risk prostate cancer who not only do not benefit from treatment but also suffer from complication caused by treatment. On the other hand, without prostate cancer screening, the rate of meta...
متن کاملباورهای بهداشتی زنان نسبت به انجام ماموگرافی در مراجعه کنندگان به مراکز بهداشتی شهر ساری در سال 1383
Background and purpose: Breast cancer is one of the most important non contagious disease with high incidence and mortality in females. It is the most commonly reported cancer and consists 18.9% of all reported cancer cases. Screening is a very important method for early diagnosis of breast cancer. Considering the important role of beliefs in performing as the most effective available meth...
متن کاملSummary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet.
OBJECTIVES To construct a European 'balance sheet' of key outcomes of population-based mammographic breast cancer screening, to inform policy-makers, stakeholders and invited women. METHODS From the studies reviewed, the primary benefit of screening, breast cancer mortality reduction, was compared with the main harms, over-diagnosis and false-positive screening results (FPRs). RESULTS Poole...
متن کاملSummary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet
Accepted for publication 13 June 2012 . . . . . . . . . . . . . . . . . . . Objectives To construct a European ‘balance sheet’ of key outcomes of population-based mammographic breast cancer screening, to inform policy-makers, stakeholders and invited women. Methods From the studies reviewed, the primary benefit of screening, breast cancer mortality reduction, was compared with the main harms, o...
متن کامل